The evolutionarily conserved presence of SAA proteins in colostrum establishes a potential role for these cytokine‐like proteins in neonatal host defense during a critical, early postnatal period and suggests possible therapeutic application(s) in conditions where exposure to these molecules may be limited (e.g. prematurity or malnutrition). This evidence concerns the gene SAA1 and malnutrition.